Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
INO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading INO News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
BCRC. R. Bard, Inc.
0.58%304.171.4%$335.55m
MDTMedtronic PLC
1.38%81.760.6%$316.27m
ABTAbbott Laboratories
-0.84%43.760.8%$299.01m
ISRGIntuitive Surgical, Inc.
0.62%827.247.8%$297.71m
TMOThermo Fisher Scientific Inc.
0.92%158.791.0%$228.57m
BDXBecton, Dickinson and Company
1.10%179.021.3%$220.20m
BSXBoston Scientific Corporation
0.70%25.741.1%$186.06m
BAXBaxter International Inc.
-0.45%53.211.4%$164.62m
EWEdwards Lifesciences Corporation
0.99%98.931.1%$150.24m
SYKStryker Corporation
0.80%135.521.5%$125.14m
HOLXHologic, Inc.
0.45%44.431.4%$98.77m
ZBHZimmer Biomet Holdings, Inc.
0.95%124.441.7%$95.21m
VARVarian Medical Systems, Inc.
0.03%88.439.2%$80.23m
IDXXIDEXX Laboratories, Inc.
0.35%162.433.7%$77.58m
WATWaters Corporation
6.58%170.813.1%$77.56m

Company Profile

Inovio Pharmaceuticals, Inc. is a bio pharmaceutical company. It develops active DNA immunotherapies for cancer and infectious diseases. The company's portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. Its pipeline consists vgx-3100, ino-3122, ino-3106, pennvax-b and pennvax-g. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.